RingMD Founder Justin Fulcher on Selling a Company the Right Way

When Justin Fulcher sold RingMD in 2018, he was careful about how he framed it. He did not describe the transaction as an exit. He described it as a continuation. “What selling a company ultimately comes down to is a shared vision,” he has said. “This is a continuation of the vision rather than a departure from it.” That framing reflected something consistent about how Justin Fulcher approaches transition not as endpoints but as structural moves within a longer arc.

The Platform Before the Sale

By the time of the sale, RingMD had grown from an unnamed prototype Fulcher built alone in Southeast Asia into a telehealth platform with regional reach and growing international momentum. Justin Fulcher had left Clemson University at nineteen and moved to Southeast Asia, where he spent seven years observing a pattern that would define the company: people with access to smartphones but no meaningful access to healthcare. The prototype he built to address that gap attracted investors before he had formalized anything.

After the 2018 sale, Fulcher spent about a year managing the handoff, including the relocation of RingMD’s headquarters from Singapore to Boston. The platform relaunched in the United States in 2019. When COVID-19 arrived in early 2020, Fulcher had returned to Charleston, South Carolina. He made a white-labeled version of the platform available at no charge to hospitals, doctors, and healthcare organizations.

A Decade of Impact

Justin Fulcher stepped away from daily operations in January 2025. By then, RingMD was present in more than fifty countries, maintained 1.5 million patient records, and worked with a provider network of 10,000. Its clients ranged from governments and hospital systems to pharmaceutical companies, reaching populations across Asia, North America, and elsewhere across three continents. Follow this page on Instagram, for more information.

Learn more about Justin Fulcher on https://www.justinfulcher.com/